You have 9 free searches left this month | to do more

ly3023414

Ly3023414 is a drug used to treat Breast Cancer, Advanced Cancer, Breast Neoplasms, and other conditions. Ly3023414 is being actively studied in 3 studies and prior, has been studied in 6.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyTennessee Oncology PLLC
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
Sarah Cannon Cancer Center
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
  • Endometrial Cancer
  • Recurrent Endometrial Cancer
  • LY3023414
  • Basking Ridge, New Jersey
  • +5 more
2021-06-16
Jun 16, 2021
E
Active, not recruiting
  • Advanced Cancer
  • +5 more
  • LY3023414
  • +6 more
  • Los Angeles, California
  • +7 more
2021-08-05
Aug 5, 2021
E
Terminated
  • Non-small Cell Lung Cancer Metastatic
  • Mobile, Alabama
  • +13 more
2020-11-13
Nov 13, 2020
E
Available
  • Cancer
  • Torrance, California
  • +2 more
2021-11-17
Nov 17, 2021
E
Completed
  • Prostate Cancer Metastatic
  • LY3023414
  • +2 more
  • Homewood, Alabama
  • +35 more
2021-04-17
Apr 17, 2021
E
Completed
  • Neoplasm Metastasis
  • +2 more
  • Sarasota, Florida
  • +4 more
2020-03-30
Mar 30, 2020
E
Active, not recruiting
  • Breast Neoplasms
  • Fayetteville, Arkansas
  • +15 more
2021-06-17
Jun 17, 2021
E
Completed
  • Solid Tumor
  • +4 more
  • Miami, Florida
  • +10 more
2020-08-13
Aug 13, 2020
E
Completed
  • Neoplasm
  • LY3023414
  • Chiba, Japan
  • +1 more
2018-07-20
Jul 20, 2018
E
Completed
  • Carcinoma, Non-small Cell Lung
  • Fayetteville, Arkansas
  • +10 more
2020-08-22
Aug 22, 2020